Healthy.Capital

What Healthy.Capital does

Healthy.Capital is a Dutch venture capital firm founded in 2018 that invests seed and pre-seed capital of EUR 200K to EUR 1M in early-stage digital health startups headquartered in the Netherlands. The firm targets portfolio companies younger than seven years that offer technology-driven solutions across digital health solutions, services, SaaS, and marketplaces, addressing structural Dutch healthcare challenges including worker shortage, rising healthcare expenses, aging populations, chronic disease prevalence, and system inefficiency. The firm acquires minority equity stakes and supports founders with coaching, operational expertise, business development, financial roadmap planning, and network expansion, with no proprietary technology platform of its own.

The firm operates two capital vehicles: a main Digital Health Fund (which had an initial closing of EUR 12 million in November 2021 with a target of at least EUR 20 million) and the Healthy.Capital Opportunity Fund, which has attracted regional impact capital such as mr. Roelsefonds. Its portfolio spans 17 companies across diverse digital health verticals, including mental healthcare (OpenUp Group, iPractice), MS care (Sherpa, Upendo), medical imaging AI (Datamonk), MedTech regulatory automation (Guideways AI), generative-AI healthcare platforms (Healthsage.ai), VR-based pain therapy (Reducept, VRelax), digital therapeutics (MiGuide), pharmacy care (Pharmi/MedicijnWijs), nutrition (Clear.bio), workforce microlearning (Primio), self-sampling diagnostics (Homed-IQ), post-surgical recovery (IkHerstel), home caregiving (Saar aan Huis), and clinical knowledge distribution (Alii). The firm is headquartered at the AOC Building, W.G. Plein 100-873, 1054 SC Amsterdam, and has a four-person partner team consisting of Douwe Jippes, Alexander van der Wyck, Karen Berg, and Thom Nefkens.

The revenue model is built on traditional venture capital mechanics: management fees on committed capital and carried interest from equity exits and growth in portfolio companies. As of 2025, measurable portfolio impact includes EUR 88.3 million of avoidable healthcare and societal costs prevented, 1,015 FTE of healthcare capacity freed up, EUR 5.19 of cost avoidance per euro invested since 2018, 42 clinical validations across the portfolio, and 5 ventures reimbursed. Healthy.Capital is also the first European VC fund to quantify portfolio-level societal impact using the LIFe Impact Framework, a coalition-developed standard launched with Invest-NL, PGGM Investments, Achmea Impact Ventures, Coöperatie VGZ, and CbusineZ in 2025.

Name

Healthy.Capital

Legal name

Healthy.Capital

Website

https://healthy.capital

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Healthy.Capital is a Dutch venture capital firm that invests EUR 200K to EUR 1M in early-stage Dutch digital health startups. Founded in 2018, it operates multiple fund vehicles and supports portfolio companies with coaching, healthcare expertise, and policy network access.

Ownership category

akta.pro rank

Product category

Venture Capital / Digital Health Investment

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Venture capital funding
• Digital health investment
• Seed stage capital
• Healthcare innovation
• Impact investment

Headquarters

HQ city

Plein

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Investment returns from portfolio companies: Healthy.Capital generates returns through equity investments in early-stage digital health startups. They acquire minority stakes in portfolio companies and benefit from exits and growth.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Healthy.Capital is a venture capital firm that invests seed and pre-seed capital (EUR 200K to EUR 1M) in early-stage Dutch digital health startups, acquiring minority equity shares. In addition to capital, the firm provides portfolio companies with coaching, operational expertise, business development support, financial roadmap planning, and access to an international network of health innovators and policymakers. The firm manages fund vehicles including the second Digital Health Fund (EUR 12 million initial closing in November 2021) and the Healthy.Capital Opportunity Fund.

Product overview

Healthy.Capital is a Dutch venture capital firm focused on digital health innovation, operating as a multi-product investment platform rather than a single-product company. The firm provides investment capital (EUR 200K to EUR 1M) and portfolio support services including strategy building, coaching, operational expertise, business development, health & care expertise, co-investments, financial roadmap planning, and network expansion to early-stage digital health startups in the Netherlands. Their portfolio comprises 17 distinct digital health companies spanning mental healthcare (OpenUp Group, iPractice), medical imaging (Datamonk), regulatory technology (Guideways AI), digital therapeutics (Reducept VR, MiGuide), medication management (Pharmi/MedicijnWijs), AI-powered healthcare (Healthsage.ai), chronic disease management (Sherpa, Upendo, Clear.bio), healthcare workforce training (Primio), diagnostics (Homed-IQ), rehabilitation (IkHerstel), caregiving (Saar aan Huis), and wellness (VRelax).

Differentiator

Problem solved

Functional benefit

Brands

• Healthy.Capital Opportunity Fund: A fund vehicle for impact investments in digital health solutions.

Products and services

• Healthy.Capital Investment Services Venture capital investment services providing seed and pre-seed equity capital (EUR 200K to EUR 1M per deal) to early-stage Dutch digital health startups, acquiring minority shares. The service includes coaching, operational expertise, business development support, financial roadmap planning, health & care expertise, co-investments, and network expansion for portfolio companies.

Quantifiable outcome

• €88.3 million in avoidable healthcare costs prevented by portfolio in 2025
• +3 more outcomes

Named customers10 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability13 records

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Heal Capital: Berlin-based venture capital firm exclusively focused on digital health, investing in early-stage European companies. Heal Capital is the closest direct European peer given its similar sector-vertical specialization and stage focus.
• Digital Health Ventures: German early-stage venture fund dedicated to digital health startups. Directly comparable as a sector-specialist digital health investor targeting seed-stage companies in Europe.

Regional players

• Peak Capital: Dutch venture capital firm investing in early-stage tech and digital companies including healthtech. Comparable as a domestic Dutch VC operating in similar seed-stage territory.
• Holland Capital: Amsterdam-based PE/VC firm with healthcare investments among its portfolio. Comparable as a Dutch investor operating in the same geography, though not exclusively focused on digital health.
• InnovationQuarter: Dutch regional development agency investing in innovative companies including digital health ventures. Comparable as a domestic capital provider in the Dutch innovation ecosystem.

Emerging players

• b2venture (formerly BioMedPartners): Swiss life-sciences venture capital firm investing in early-stage healthcare and biotech companies. Comparable as a sector-focused European healthcare investor with similar early-stage orientation.

Broad incumbents

• Speedinvest: Austrian early-stage VC with a dedicated Health & Tech vertical. Comparable as a European digital health investor at seed stage, though operating as a multi-sector generalist rather than a pure vertical specialist.
• Octopus Ventures: UK-based VC with a dedicated health and biotech practice. Comparable as a European digital health investor, though operating at much larger AUM and broader sector scope.
• HV Capital: German venture capital firm with healthcare and digital health investments across its funds. Comparable as a European early-stage VC with health sector exposure, though broader in mandate.
• AXA Venture Partners: European venture capital firm with a dedicated digital health fund investing in growth-stage healthtech companies. Comparable as a European institutional VC targeting healthcare innovation, though at larger check sizes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/healthydotcapital

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments12 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Healthy.Capital